Provided by Tiger Trade Technology Pte. Ltd.

Repligen

178.19
+5.283.05%
Post-market: 178.00-0.1900-0.11%19:30 EDT
Volume:1.09M
Turnover:192.73M
Market Cap:10.03B
PE:244.10
High:178.65
Open:174.93
Low:173.24
Close:172.91
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.32
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.75
PE(LYR):207.20

Loading ...

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Repligen to Buy Biolife Solutions for About USD 1.5 Billion, Offers USD 31 a Share

Reuters
·
Jul 22

Biolife Solutions - Repligen to Buy Biolife for $1.50 Bln Enterprise Value, 64% Stock, 36% Cash

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Repligen Preliminary Q2 Reported Revenue Growth 12%, Organic Revenue Growth 13%

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Stockholders to Receive $11.25 Cash and 0.1442 Repligen Shares Per Biolife Share

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Preliminary Q2 Revenue Growth 21% Year-over-year

THOMSON REUTERS
·
Jul 22

Repligen to Acquire Biolife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Repligen Expects at Least $20 Mln Synergies in Year One, $30 Mln in Year Two

THOMSON REUTERS
·
Jul 22

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

GlobeNewswire
·
Jul 22

Earnings Preview: Repligen revenue is expected to increase by 15%, and institutional views are constructive

Earnings Agent
·
Jul 21

Repligen CFO Jason K. Garland Sells 530 Common Shares for $79,500

Reuters
·
Jul 18

Repligen to Report Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 15

Repligen Stock And 2 Dollar Beneficiaries Gaining Attention After Fed Rate Shift

Simply Wall St.
·
Jul 13

Can Repligen (RGEN) Stay Undervalued On Russell Index Removals And Margin Concerns?

Simply Wall St.
·
Jul 10

Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors?

Simply Wall St.
·
Jul 08

Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185

MT Newswires Live
·
Jul 07

Repligen Corp : Benchmark Raises to Buy from Hold

THOMSON REUTERS
·
Jul 07

Repligen is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Q/C Technologies Relocates Headquarters to San Francisco, Sets up 4,800-square-foot Photonics Lab

Reuters
·
Jul 03

Biolife attracts takeover interest from Repligen, Bloomberg says

TIPRANKS
·
Jun 27